Does STREPTOZOCIN Cause Malignant neoplasm progression? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Malignant neoplasm progression have been filed in association with STREPTOZOCIN (Zanosar). This represents 17.6% of all adverse event reports for STREPTOZOCIN.
31
Reports of Malignant neoplasm progression with STREPTOZOCIN
17.6%
of all STREPTOZOCIN reports
3
Deaths
20
Hospitalizations
How Dangerous Is Malignant neoplasm progression From STREPTOZOCIN?
Of the 31 reports, 3 (9.7%) resulted in death, 20 (64.5%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for STREPTOZOCIN. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does STREPTOZOCIN Cause?
Product use in unapproved indication (29)
Drug ineffective (25)
Toxicity to various agents (24)
Hypoglycaemia (23)
Nausea (23)
Nephropathy toxic (23)
Off label use (23)
Chronic kidney disease (22)
Fatigue (22)
Pancreatic neuroendocrine tumour (21)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which STREPTOZOCIN Alternatives Have Lower Malignant neoplasm progression Risk?
STREPTOZOCIN vs STRIBILD
STREPTOZOCIN vs SUBOXONE
STREPTOZOCIN vs SUBUTEX
STREPTOZOCIN vs SUCCINYLCHOLINE
STREPTOZOCIN vs SUCRALFATE